Longeveron INC. (LGVN) — 8-K Filings

All 8-K filings from Longeveron INC.. Browse 27 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (27)

Longeveron Inc. Announces Board Changes and CMO Departure — Nov 12, 2025 Risk: medium
Longeveron Inc. announced on November 7, 2025, the departure of its Chief Medical Officer, Dr. Anthony D. D'Souza. The company also reported the election of two
Longeveron Inc. Files 8-K on Financials — Nov 4, 2025 Risk: low
Longeveron Inc. filed an 8-K on November 4, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and e
Longeveron Inc. Reports Director/Officer Changes & Financials — Oct 1, 2025 Risk: medium
Longeveron Inc. filed an 8-K on October 1, 2025, reporting events as of September 25, 2025. The filing pertains to the departure of directors or certain officer
Longeveron Faces Delisting Concerns — Sep 26, 2025 Risk: high
Longeveron Inc. filed an 8-K on September 26, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing indicates a poten
Longeveron Inc. Files 8-K for Material Agreement — Sep 19, 2025 Risk: medium
Longeveron Inc. filed an 8-K on September 19, 2025, reporting the entry into a material definitive agreement and filing financial statements and exhibits. The f
Longeveron Inc. Files 8-K on Officer/Director Changes & Financials — Sep 3, 2025 Risk: medium
Longeveron Inc. filed an 8-K on September 3, 2025, reporting on events that occurred on August 27, 2025. The filing pertains to the departure of directors or ce
Longeveron Inc. Files 8-K on Financials — Aug 13, 2025 Risk: low
Longeveron Inc. filed an 8-K on August 13, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. T
Longeveron Inc. Files 8-K: Material Agreement & Financials — Aug 11, 2025 Risk: medium
Longeveron Inc. announced on August 8, 2025, the entry into a material definitive agreement. The company also filed financial statements and exhibits as part of
Longeveron Inc. Files 8-K Reporting Other Events — Jul 9, 2025 Risk: low
Longeveron Inc. filed an 8-K on July 9, 2025, reporting other events and financial statements as of July 8, 2025. The company, incorporated in Delaware, is base
Longeveron Inc. Files 8-K on Shareholder Votes and Financials — Jun 16, 2025 Risk: low
Longeveron Inc. filed an 8-K on June 13, 2025, reporting on the submission of matters to a vote of security holders and financial statements. The filing details
Longeveron Inc. Files 8-K on Financials — May 8, 2025 Risk: low
Longeveron Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibi
Longeveron Inc. Shuffles Leadership and Board — May 1, 2025 Risk: medium
Longeveron Inc. announced on April 24, 2025, the departure of Dr. Paul L. Kaloostian as Chief Medical Officer and the appointment of Dr. Joshua M. Hare as inter
Longeveron Changes Independent Auditor to Marcum LLP — Mar 14, 2025 Risk: low
Longeveron Inc. filed an 8-K on March 13, 2025, to report a change in its certifying accountant. The company has appointed Marcum LLP as its new independent reg
Longeveron Inc. Files 8-K for FY 2024 Results — Feb 28, 2025 Risk: medium
Longeveron Inc. filed an 8-K on February 28, 2025, reporting its financial results for the fiscal year ending December 31, 2024. The filing details the company'
Longeveron Appoints New CMO, Adds Director — Jan 30, 2025 Risk: medium
Longeveron Inc. announced on January 27, 2025, the appointment of Dr. Geoff Thea as Chief Medical Officer and the election of Dr. R. Scott Nolen to its Board of
Longeveron Inc. Files 8-K on Financials — Nov 12, 2024 Risk: low
Longeveron Inc. filed an 8-K on November 12, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and
Longeveron Inc. Files 8-K: Material Agreement & Equity Sales — Jul 19, 2024 Risk: medium
Longeveron Inc. announced on July 18, 2024, that it entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity secu
Longeveron Inc. Files 8-K for Other Events — Jul 17, 2024 Risk: medium
Longeveron Inc. filed an 8-K on July 17, 2024, to report other events and financial statements. The filing does not contain specific details about new events or
Longeveron Inc. Files 8-K for Other Events — Jul 10, 2024 Risk: low
Longeveron Inc. filed an 8-K on July 10, 2024, to report other events and financial statements. The filing does not detail specific transactions or financial re
Longeveron Inc. Files 8-K on Shareholder Votes and Financials — Jul 3, 2024 Risk: low
Longeveron Inc. filed an 8-K on July 3, 2024, reporting on a submission of matters to a vote of security holders and financial statements. The filing date for t
Longeveron Inc. Files 8-K for Material Agreement — Jun 18, 2024 Risk: medium
Longeveron Inc. announced on June 17, 2024, that it entered into a Material Definitive Agreement. The company also disclosed unregistered sales of equity securi
Longeveron Inc. Faces Delisting Concerns — May 10, 2024 Risk: high
Longeveron Inc. filed an 8-K on May 10, 2024, reporting a notice of delisting or failure to satisfy continued listing rules, along with changes in directors and
Longeveron Raises $1M in Stock and Warrant Sale — Apr 18, 2024 Risk: medium
Longeveron Inc. announced on April 16, 2024, that it entered into a Securities Purchase Agreement with an accredited investor for the sale of 1,000,000 shares o
Longeveron Inc. Files 8-K: Material Definitive Agreement — Apr 11, 2024 Risk: medium
Longeveron Inc. announced on April 8, 2024, that it entered into a Material Definitive Agreement. The filing also includes other events and financial statements
Longeveron Files 8-K with Bylaw Amendments & Exhibits — Mar 19, 2024 Risk: low
Longeveron Inc. filed an 8-K on March 19, 2024, reporting amendments to its articles of incorporation or bylaws, a Regulation FD disclosure, and financial state
Longeveron Faces Nasdaq Delisting Warning — Mar 7, 2024 Risk: high
Longeveron Inc. received a notice on March 4, 2024, indicating it failed to meet the minimum bid price requirement for continued listing on the Nasdaq Capital M
Longeveron Files 8-K on Shareholder Vote Submission — Feb 22, 2024 Risk: low
Longeveron Inc. filed an 8-K on February 22, 2024, reporting on a matter submitted to a vote of security holders on February 21, 2024. The filing indicates that

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX